Sex Differences in HIV: Natural History, Pharmacokinetics, and Drug Toxicity

Overview

Journal Curr Infect Dis Rep

Specialty Infectious Diseases

Date 2004 Dec 22

PMID 15610674

Citations 3

Authors

Obiamiwe C Umeh

Judith S Currier

Affiliations

Soon will be listed here.

Abstract

In the early years of the HIV epidemic, the burden of the disease was principally among men. In recent years, HIV infection among women has become a growing problem worldwide. There is now an increasing awareness that HIV may affect men and women differently. New data have emerged from studies that have focused on HIV-infected women, suggesting the existence of sex-related differences in natural history, pharmacokinetics, and toxicity of antiretroviral therapy. This paper reviews the current literature with an emphasis on recent data regarding sex differences in HIV that have implications for clinical practice.

Citing Articles

Cardiovascular disease risk among women living with HIV in North America and Europe.

Stone L, Looby S, Zanni M Curr Opin HIV AIDS. 2017; 12(6):585-593.

PMID: 28832367 PMC: 6002961. DOI: 10.1097/COH.0000000000000413.

Discordance between CD4+ T-lymphocyte counts and percentages in HIV-infected persons with liver fibrosis.

Claassen C, Diener-West M, Mehta S, Thomas D, Kirk G Clin Infect Dis. 2012; 54(12):1806-13.

PMID: 22460963 PMC: 3404711. DOI: 10.1093/cid/cis294.

Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.

Bazzoli C, Benech H, Rey E, Retout S, Salmon D, Duval X Antimicrob Agents Chemother. 2011; 55(7):3423-31.

PMID: 21576446 PMC: 3122424. DOI: 10.1128/AAC.01487-10.

References

Gilad J, Walfisch A, Borer A, Schlaeffer F . Gender differences and sex-specific manifestations associated with human immunodeficiency virus infection in women. Eur J Obstet Gynecol Reprod Biol. 2003; 109(2):199-205. DOI: 10.1016/s0301-2115(03)00048-4. View

Nasti G, Serraino D, Ridolfo A, Antinori A, Rizzardini G, Zeroli C . AIDS-associated Kaposi's sarcoma is more aggressive in women: a study of 54 patients. J Acquir Immune Defic Syndr Hum Retrovirol. 1999; 20(4):337-41. DOI: 10.1097/00042560-199904010-00003. View

Delmas M, Jadand C, de Vincenzi I, Deveau C, Persoz A, Sobel A . Gender difference in CD4+ cell counts persist after HIV-1 infection. SEROCO Study Group. AIDS. 1997; 11(8):1071-3. View

. Heterosexual transmission of HIV--29 states, 1999-2002. MMWR Morb Mortal Wkly Rep. 2004; 53(6):125-9. View

Fletcher C, Jiang H, Brundage R, Acosta E, Haubrich R, Katzenstein D . Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group Study 359. J Infect Dis. 2004; 189(7):1176-84. DOI: 10.1086/382754. View

Junghans C, Low N, Chan P, Witschi A, Vernazza P, Egger M . Uniform risk of clinical progression despite differences in utilization of highly active antiretroviral therapy: Swiss HIV Cohort Study. AIDS. 2000; 13(18):2547-54. DOI: 10.1097/00002030-199912240-00008. View

Campisi G, Pizzo G, Mancuso S, Margiotta V . Gender differences in human immunodeficiency virus-related oral lesions: an Italian study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 91(5):546-51. DOI: 10.1067/moe.2001.113548. View

Melnick S, Sherer R, Louis T, Hillman D, Rodriguez E, Lackman C . Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS. JAMA. 1994; 272(24):1915-21. View

Phillips A, Antunes F, Stergious G, Ranki A, Jensen G, Bentwich Z . A sex comparison of rates of new AIDS-defining disease and death in 2554 AIDS cases. AIDS in Europe Study Group. AIDS. 1994; 8(6):831-5. DOI: 10.1097/00002030-199406000-00017. View

10.

Anthony M, Berg M . Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part I. J Womens Health Gend Based Med. 2002; 11(7):601-15. DOI: 10.1089/152460902760360559. View

11.

Gandhi M, Bacchetti P, Miotti P, Quinn T, Veronese F, Greenblatt R . Does patient sex affect human immunodeficiency virus levels?. Clin Infect Dis. 2002; 35(3):313-22. DOI: 10.1086/341249. View

12.

Moore A, Kirk O, Johnson A, Katlama C, Blaxhult A, Dietrich M . Virologic, immunologic, and clinical response to highly active antiretroviral therapy: the gender issue revisited. J Acquir Immune Defic Syndr. 2003; 32(4):452-61. DOI: 10.1097/00126334-200304010-00017. View

13.

Uppal S, Verma S, Dhot P . Normal values of CD4 and CD8 lymphocyte subsets in healthy indian adults and the effects of sex, age, ethnicity, and smoking. Cytometry B Clin Cytom. 2003; 52(1):32-6. DOI: 10.1002/cyto.b.10011. View

14.

Mocroft A, Gill M, Davidson W, Phillips A . Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care?. J Acquir Immune Defic Syndr. 2000; 24(5):475-82. DOI: 10.1097/00126334-200008150-00013. View

15.

Saada M, Le Chenadec J, Berrebi A, Bongain A, Delfraissy J, Mayaux M . Pregnancy and progression to AIDS: results of the French prospective cohorts. SEROGEST and SEROCO Study Groups. AIDS. 2000; 14(15):2355-60. DOI: 10.1097/00002030-200010200-00017. View

16.

Gandhi M, Aweeka F, Greenblatt R, Blaschke T . Sex differences in pharmacokinetics and pharmacodynamics. Annu Rev Pharmacol Toxicol. 2004; 44:499-523. DOI: 10.1146/annurev.pharmtox.44.101802.121453. View

17.

Prins M, Robertson J, Brettle R, Aguado I, Broers B, Boufassa F . Do gender differences in CD4 cell counts matter?. AIDS. 1999; 13(17):2361-4. DOI: 10.1097/00002030-199912030-00007. View

18.

Wolbold R, Klein K, Burk O, Nussler A, Neuhaus P, Eichelbaum M . Sex is a major determinant of CYP3A4 expression in human liver. Hepatology. 2003; 38(4):978-88. DOI: 10.1053/jhep.2003.50393. View

19.

Miller W, Aberg J, van der Horst C, Hamrick Jr H, Powderly W, Mundy L . Sex differences in nevirapine rash. Clin Infect Dis. 2000; 32(1):124-9. DOI: 10.1086/317536. View

20.

Napravnik S, Poole C, Thomas J, Eron Jr J . Gender difference in HIV RNA levels: a meta-analysis of published studies. J Acquir Immune Defic Syndr. 2002; 31(1):11-9. DOI: 10.1097/00126334-200209010-00002. View